A node between proliferation, apoptosis, and growth arrest

BioEssays

Volumn 21, Issue 8, 1999, Pages 704-709

  Blagosklonny, Mikhail V ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; CELL DIVISION; GENETICS; HUMAN; ONCOGENE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; MODELS, BIOLOGICAL; ONCOGENES; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0033179737     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199908)21:8<704::AID-BIES10>3.0.CO;2-5     Document Type: Review

References (72)

1. Collins MKL, Perkins GR, Rodriguez-Tarduchy G, Nieto MA, Lopez-Rivas A. Growth factors as survival factors: regulation of apoptosis. BioEssays 1994;16:133-138.
2. Baserga R. Oncogenes and the strategy of growth factors. Cell 1994;79: 927-930.
3. Hunter T. Oncoprotein networks. Cell 1997;88:333-346.
4. Evan Gl, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-128.
5. Huang TS, Duyster J, Wang JY. Biological response to phorbol ester determined by alternative G1 pathways. Proc Natl Acad Sci USA 1995;92: 4793-4797.
6. Marshall CJ. Specificity of receptor tyrosine kinase signaling-transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-185.
7. Pumiglia KM, Decker SJ. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997;94:448-452.
8. Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M, Land H. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 1997;11:663-677.
9. Fan Z, Lu Y, Wu X, DeBlasio A, Koff A, Mendelsohn J. Prolong induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor mediates ligand induced A431 cell growth inhibition. J Cell Biol 1995;131:235-242.
10. Sewing A, Wiseman B, Lloyd AC, Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 1997;17:5588-5597.
11. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 Mol Cell Biol 1997;17:5598-5611.
12. Kerkhoff E, Rapp UR. High-intensity Raf signals convert mitoticcell cycling into cellular growth. Cancer Res 1998;58:1636-1640.
13. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998;92:725-734.
14. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-723.
15. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 1998;12:2424-2433.
16. de Stanchina E, McCurrach ME, Zindy F, Shieh S-Y, Ferbeyre G, Samuelson AV, Prives C, Roussel MF Sherr CJ, Lowe SW. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev 1998:12:2434-2442.
17. Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA, Barrett JC. Induction of apoptosis by c-Fos protein. Mol Cell Biol 1996;16:211-218.
18. Qin XQ, Livingston DM, Kaelin WG, Adams PD. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 1994;91:10918-10922.
19. Wu X, Levine AJ. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994;91:3602-3606.
20. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 1995;69:2491-2500.
21. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 1997;94:7245-7250.
22. Sofer-Levi Y, Resnitzky D Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene 1996;13:2431-2437.
23. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 1992;89:7742-7746.
24. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
25. Oswald F, Lovec H, Moray T, Lipp M. E2F-dependent regulation of human MYC: trans activation by cyclins D1 and A overrides tumour suppressor protein function. Oncogene 1994;9:2029-2036.
26. Harrington E, Fanidi A, Bennet M, Evan G. Modulation of Myc-induced apoptosis by specific cytokines. EMBO J 1994;13:3286-3295.
27. Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998;281: 1312-1316.
28. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318-1321.
29. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G. Suppression of c-myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997;385:544-548.
30. Shim H, Chun YS, Lewis BC, Dang CV. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci USA 1998:95: 1511-1516.
31. Wang HG, Rapp UR, Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996;87:629-639.
32. Zha JP, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BGL-X(L). Cell 1996;87:619-628.
33. Somasundaram K, El-Deiry WS. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 1997;14:1047-1057.
34. Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM. Binding and modulation of p53 by p300/CBP coactivators. Nature 1997;387:823-827.
35. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 1997; 89;1175-1184.
36. Thomas A, White E. Suppression of the p300-dependent mdm2 negative-feedback loop induces the apoptotic function. Genes Dev 1998;12:1975-1985.
37. Chiou SK, White E. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J Virol 1997;71:3515-3525.
38. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF, Livingston DM. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 1996;93:12969-12973.
39. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 1998;273:11995-11998.
40. Ravi R, Mookerjee B, van Hensbergen Y, Bedi GC, Giordano A, El-Deiry WS, Fuchs EJ, Bedi A. p53-mediated repression of nuclear factor-kappa B Rel via the transcriptional integrator p300. Cancer Res 1998;58:4531-4536.
41. Phillips AC, Bates S, Ryan KM, Helin K, Vousden KH. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev 1997;11:1853-1863.
42. Facchini LM, Penn LZ. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J 1998;12: 633-651.
43. Shen Y, Shenk T. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc Natl Acad Sci USA 1994;91:8940-8944.
44. Bates S, Phillips A, Clarke P, Stott F, Peters G, Ludwig R, Vousden KH. p14ARF links the tumor suppressors RB and p53. Nature 1998;395:124-125.
45. Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Van Dyke T. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell 1998;2:283-292.
46. Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996;85:537-548.
47. El-Deiry WS, Tokino T, Veculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
48. Zou X, Rudchenko S, Wong K, Calame K. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes & Dev 1997;11:654-662.
49. Aktas H, Cai H, Cooper GM. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol 1997;17:3850-3857.
50. Liu Y, Martindale JL, Gorospe M, Holbrook NJ. Regulation of p21 WAF1/CIP1 expression through Mitogen-activated protein kinase signaling pathway. Cancer Res 1996;56:31-35.
51. Winston JT, Coats SR, Wang YZ, Pledger WJ. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 1996:12:127-134.
52. Filmus J, Robles Al, Shi W, Wong MJ, Colombo LL, Conti CJ. Induction of cyclin D1 overexpression by activated ras. Oncogene 1994;9:3627-3633.
53. Kerkhoff E, Houben R, Loffler S, Troppmair J, Lee JE, Rapp UR. Regulation of c-myc expression by Ras/Raf signalling. Oncogene 1998;16:211-216.
54. Zeng YX, El-Deiry WS. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 1996;12:1557-1565.
55. Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 1995:9:600-611.
56. Zhu J, Woods D, McMahon M, Bishop JM. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 1998:12:2997-3007.
57. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996;93:13742-13747.
58. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997;91: 649-659.
59. Blagosklonny MV, Prabhu NS, EI-Deiry WS. Defects in p21 WAF1/CIP1, Rb, c-myc signaling in phorbol ester-resistant cancer cells. Cancer Res 1997;57:320-325.
60. DeGregori J, Leone G, Ohtani K, Miron A, Nevins J. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev 1995;9:2873-2887.
61. Desrivieres S, Volarevic S, Mercep L, Ferrari S. Evidence for different mechanisms of growth inhibition of T-cell lymphoma by phorbol esters and concanavalin A J Biol Chem 1997;272:2470-2476.
62. Coppock DL, Buffolino P, Kopman C, Nathanson L. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-0-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Exp Cell Res 1995;221:92-102.
63. Burger C, Wick M, Muller R. Lineage-specific regulation of cell cycle gene expression in differentiating myeloid cells. J Cell Sci 1994;107:2047-2054.
64. Miyazono K, Ten Dijke P, Yamashita H, Heldin CH. Signal transducton via serine/threonine kinase receptors. Semin Cell Biol 1994;5:389-398.
65. Missero C, Di Cunto F, Kiyokawa H, Koff A, Dotto GP. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 1996;10:3065-3075.
66. Nevins JR. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Diff 1998;9:585-593.
67. Brugarolas J, Bronson RT, Jacks T. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol 1998;141: 503-514.
68. Weinberg RA. E2F and cell proliferation: a world turned upside down. Cell 1996;85:457-459.
69. Alexandrow MG, Kawabata M, Aakre M, Moses HL. Overexpression of the c-myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor b1. Proc Natl Acad Sci USA 1995;92:3239-3243.
70. Dimri GP, Nakanishi M, Desperez P-Y, Smith JR, Campisi J. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol 1996;16:2987-2997.
71. Chen YQ, Cipriano SC, Arenkiel JM, Miller FR. Tumor suppression by p21/Waf1. Cancer Res 1995;55:4536-4539.
72. Zhang H, Hannon GJ, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994;8:1750-1758.